241 related articles for article (PubMed ID: 35633503)
21. Intratumoral CD38
Zhu H; Xu J; Wang W; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
EBioMedicine; 2024 May; 103():105098. PubMed ID: 38608514
[TBL] [Abstract][Full Text] [Related]
22. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
[TBL] [Abstract][Full Text] [Related]
23. The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma.
Ma H; Chen X; Mo S; Mao X; Chen J; Liu Y; Lu Z; Yu S; Chen J
Theranostics; 2023; 13(13):4601-4614. PubMed ID: 37649613
[No Abstract] [Full Text] [Related]
24. Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells.
Zhao Z; Lin Z; Guo X; Al-Danakh A; He H; Qin H; Ma C; Zhang N; Tan G
J Immunol Res; 2023; 2023():4311388. PubMed ID: 37050932
[TBL] [Abstract][Full Text] [Related]
25. PLA2G2A
Ge W; Yue M; Lin R; Zhou T; Xu H; Wang Y; Mao T; Li S; Wu X; Zhang X; Wang Y; Ma J; Wang Y; Xue S; Shentu D; Cui J; Wang L
Cancer Lett; 2023 Apr; 558():216095. PubMed ID: 36796670
[TBL] [Abstract][Full Text] [Related]
26. Hyperglycosylation of prosaposin in tumor dendritic cells drives immune escape.
Sharma P; Zhang X; Ly K; Kim JH; Wan Q; Kim J; Lou M; Kain L; Teyton L; Winau F
Science; 2024 Jan; 383(6679):190-200. PubMed ID: 38207022
[TBL] [Abstract][Full Text] [Related]
27. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
[No Abstract] [Full Text] [Related]
28. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas.
Zhuang H; Wang S; Chen B; Zhang Z; Ma Z; Li Z; Liu C; Zhou Z; Gong Y; Huang S; Hou B; Chen Y; Zhang C
Front Immunol; 2021; 12():790661. PubMed ID: 34925373
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinoma.
Jiang Y; Han L; Yang J; Yang M; Zhang J; Xue M; Zhu Y; Xiong C; Shi M; Zhao S; Shen B; Xu Z; Jiang L; Chen H
Cancer Immunol Immunother; 2023 Aug; 72(8):2701-2716. PubMed ID: 37097516
[TBL] [Abstract][Full Text] [Related]
30. PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8
Yamaki S; Yanagimoto H; Tsuta K; Ryota H; Kon M
Int J Clin Oncol; 2017 Aug; 22(4):726-733. PubMed ID: 28314962
[TBL] [Abstract][Full Text] [Related]
31. A Single-Cell Atlas of Tumor-Infiltrating Immune Cells in Pancreatic Ductal Adenocarcinoma.
Wang H; Chen L; Qi L; Jiang N; Zhang Z; Guo H; Song T; Li J; Li H; Zhang N; Chen R
Mol Cell Proteomics; 2022 Aug; 21(8):100258. PubMed ID: 35718340
[TBL] [Abstract][Full Text] [Related]
32. Tissue-resident CXCR4
Liao Z; Ye L; Li T; Jin X; Lin X; Fei Q; Zhang H; Shi S; Yu X; Jin K; Wu W
Int J Cancer; 2023 Jun; 152(11):2396-2409. PubMed ID: 36757203
[TBL] [Abstract][Full Text] [Related]
33. Plasma lipid levels are associated with the CD8+ T-cell infiltration and prognosis of patients with pancreatic cancer.
Wu B; Shen W; Wang X; Wang J; Zhong Z; Zhou Z; Chen X
Cancer Med; 2023 Jul; 12(13):14138-14148. PubMed ID: 37184113
[TBL] [Abstract][Full Text] [Related]
34. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
[TBL] [Abstract][Full Text] [Related]
35. Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features.
Pineda S; López de Maturana E; Yu K; Ravoor A; Wood I; Malats N; Sirota M
Front Immunol; 2021; 12():730746. PubMed ID: 34630409
[TBL] [Abstract][Full Text] [Related]
36. [Pathological features related to onco-immunity and their clinical significance of pancreatic ductal adenocarcinoma].
Wang CM; Xu CY; Jiang S; Zhou Q; Jiang ZJ; Cheng GP; Wu MJ; Feng TT; Yin WJ
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):419-424. PubMed ID: 35511637
[No Abstract] [Full Text] [Related]
37. Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.
Liu L; Qi Y; Huang D; Xu Y; Li M; Hong Z; Gu Y; Jia B; Luo X; Zhang S; Zhang S
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195850
[TBL] [Abstract][Full Text] [Related]
38. The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).
Lianyuan T; Dianrong X; Chunhui Y; Zhaolai M; Bin J
Cancer Biol Ther; 2018 Apr; 19(4):296-305. PubMed ID: 29313457
[TBL] [Abstract][Full Text] [Related]
39. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
40. Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer.
De Sanctis F; Dusi S; Caligola S; Anselmi C; Petrova V; Rossi B; Angelini G; Erdeljan M; Wöll S; Schlitter AM; Metzler T; Steiger K; Borok Z; Bailey P; Bauer A; Halin C; Boschi F; Giugno R; Canè S; Lawlor R; Corbo V; Scarpa A; Constantin G; Ugel S; Vascotto F; Sahin U; Türeci Ö; Bronte V
Immunity; 2024 Jun; 57(6):1378-1393.e14. PubMed ID: 38749447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
